There is controversy over whether glucagon-like peptide (GLP-1) has effects on peripheral glucose uptake which can be attributed to GLP-1 per se (i.e., separate from its insulinotrophic effects). Furthermore, there may be an organ specific differential effect between GLP-1 and GLP-1amide.
The aim of this study is to first examine the effect of GLP-1 influsion during a period of maintained euglycemia on glucose uptake and hepatic glucose production (HGP). In the second study, which will be repeated at least htree weeks after the first study, volunteers will receive an influsion of insulin in a manner which results in plasma insulin profile nearly identical to those induced by the infusion of GLP-1. If GLP-1 does indeed have insulin-like effects separate from hyperinsulinemia with respect to glucose metabolized (M), then M in the first study should be greater than M in the second study. If this is true, then a third study will be performed where the insulin dose will be increased in order to produce an equivalent glucose utilization to that obtained in the first study. This will quantify the extent of GLP-1's insulin-like effect with respect to glucose uptake per se. If M is not different between study 1 and 2 with the use of GLP-1, GLP-1 will be infused to test whether organ- specific receptor differences are present in the liver and the muscle bed. It has been shown that there are no insulinotrophic differences between these two peptides in humans. However, there is controversy whether or not GLP-1 has any insulin-like effects on glucose uptake and production in the muscle and liver.
|Li, Tianjing; Wieland, L Susan; Oh, Esther et al. (2017) Design considerations of a randomized controlled trial of sedation level during hip fracture repair surgery: a strategy to reduce the incidence of postoperative delirium in elderly patients. Clin Trials 14:299-307|
|Sammut, Amanda; Shea, Steven; Blumenthal, Roger S et al. (2017) Albuminuria in Rheumatoid Arthritis: Associations With Rheumatoid Arthritis Characteristics and Subclinical Atherosclerosis. Arthritis Care Res (Hoboken) 69:1799-1808|
|Baker, Joshua F; Giles, Jon T; Weber, David et al. (2017) Assessment of muscle mass relative to fat mass and associations with physical functioning in rheumatoid arthritis. Rheumatology (Oxford) 56:981-988|
|Johnson, Karen C; Bray, George A; Cheskin, Lawrence J et al. (2017) The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial. J Bone Miner Res 32:2278-2287|
|Chao, Ariana M; Wadden, Thomas A; Gorin, Amy A et al. (2017) Binge Eating and Weight Loss Outcomes in Individuals with Type 2 Diabetes: 4-Year Results from the Look AHEAD Study. Obesity (Silver Spring) 25:1830-1837|
|Park, H-W; Tse, S; Yang, W et al. (2017) A genetic factor associated with low final bone mineral density in children after a long-term glucocorticoids treatment. Pharmacogenomics J 17:180-185|
|Unick, Jessica L; Gaussoin, Sarah A; Hill, James O et al. (2017) Objectively Assessed Physical Activity and Weight Loss Maintenance among Individuals Enrolled in a Lifestyle Intervention. Obesity (Silver Spring) 25:1903-1909|
|McGeachie, Michael J; Yates, Katherine P; Zhou, Xiaobo et al. (2016) Genetics and Genomics of Longitudinal Lung Function Patterns in Individuals with Asthma. Am J Respir Crit Care Med 194:1465-1474|
|Marquez, Becky; Anderson, Andrea; Wing, Rena R et al. (2016) The relationship of social support with treatment adherence and weight loss in Latinos with type 2 diabetes. Obesity (Silver Spring) 24:568-75|
|Kavouspour, Chitra; Wang, NaeYuh; Mears, Simon C et al. (2016) Surgical procedure and postoperative delirium in geriatric hip fracture patients. Eur J Anaesthesiol 33:230-1|
Showing the most recent 10 out of 406 publications